These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20368302)

  • 1. Differences in progression of CKD and mortality amongst Caucasian, Oriental Asian and South Asian CKD patients.
    Barbour SJ; Er L; Djurdjev O; Karim M; Levin A
    Nephrol Dial Transplant; 2010 Nov; 25(11):3663-72. PubMed ID: 20368302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.
    Lundström UH; Gasparini A; Bellocco R; Qureshi AR; Carrero JJ; Evans M
    BMC Nephrol; 2017 Feb; 18(1):59. PubMed ID: 28187786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
    Jones C; Roderick P; Harris S; Rogerson M
    Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
    Inaguma D; Imai E; Takeuchi A; Ohashi Y; Watanabe T; Nitta K; Akizawa T; Matsuo S; Makino H; Hishida A;
    Clin Exp Nephrol; 2017 Jun; 21(3):446-456. PubMed ID: 27412450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between GFR, proteinuria, and adverse outcomes among White, Chinese, and South Asian individuals in Canada.
    Conley J; Tonelli M; Quan H; Manns BJ; Palacios-Derflingher L; Bresee LC; Khan N; Hemmelgarn BR;
    Am J Kidney Dis; 2012 Mar; 59(3):390-9. PubMed ID: 22115883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with kidney disease progression and mortality in a referred CKD population.
    Hoefield RA; Kalra PA; Baker P; Lane B; New JP; O'Donoghue DJ; Foley RN; Middleton RJ
    Am J Kidney Dis; 2010 Dec; 56(6):1072-81. PubMed ID: 20692750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
    Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
    Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.
    Swartling O; Rydell H; Stendahl M; Segelmark M; Trolle Lagerros Y; Evans M
    Am J Kidney Dis; 2021 Aug; 78(2):190-199.e1. PubMed ID: 33434591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A; Djurdjev O; Beaulieu M; Er L
    Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system.
    Derose SF; Rutkowski MP; Crooks PW; Shi JM; Wang JQ; Kalantar-Zadeh K; Kovesdy CP; Levin NW; Jacobsen SJ
    Am J Kidney Dis; 2013 Aug; 62(2):236-44. PubMed ID: 23499049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitions of progression in chronic kidney disease--predictors and relationship to renal replacement therapy in a population cohort with a 6 year follow-up.
    Marks A; Fluck N; Prescott GJ; Robertson LM; Simpson WG; Smith WC; Black C
    Nephrol Dial Transplant; 2014 Feb; 29(2):333-41. PubMed ID: 24081862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.
    Nacak H; van Diepen M; Qureshi AR; Carrero JJ; Stijnen T; Dekker FW; Evans M
    Nephrol Dial Transplant; 2015 Dec; 30(12):2039-45. PubMed ID: 26185050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of CKD patients receiving outpatient nephrology care in Italy.
    De Nicola L; Chiodini P; Zoccali C; Borrelli S; Cianciaruso B; Di Iorio B; Santoro D; Giancaspro V; Abaterusso C; Gallo C; Conte G; Minutolo R;
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2421-8. PubMed ID: 21817127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
    Chinnadurai R; Flanagan E; Jayson GC; Kalra PA
    BMC Nephrol; 2019 Oct; 20(1):380. PubMed ID: 31640599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UK Renal Registry 16th annual report: chapter 6 demographics and outcomes of patients from different ethnic groups on renal replacement therapy in the UK.
    Udayaraj U; Pruthi R; Casula A; Roderick P
    Nephron Clin Pract; 2013; 125(1-4):111-25. PubMed ID: 24662170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities and outcomes in South Asian individuals with chronic kidney disease: an observational primary care cohort.
    Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
    Nephrol Dial Transplant; 2021 Dec; 37(1):108-114. PubMed ID: 33439998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes in patients with chronic kidney disease: a 5-year retrospective cohort study at a University Hospital in Japan.
    Yamashita T; Yoshida T; Ogawa T; Tsuchiya K; Nitta K
    Clin Exp Nephrol; 2011 Dec; 15(6):831-40. PubMed ID: 21800234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort.
    Obi Y; Kimura T; Nagasawa Y; Yamamoto R; Yasuda K; Sasaki K; Kitamura H; Imai E; Rakugi H; Isaka Y; Hayashi T
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1558-65. PubMed ID: 20558563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.